EUVIMEDEUVIMED entdecken
Crossref

Discovery of New Quinoxaline, Tetracyclic‐Quinoxaline, and Imidazo[2,1‐ a ]isoindole Derivatives as Potent Antibacterial Candidates Targeting DNA Gyrase and Topoisomerase IV With Molecular Modeling Simulations

Ahmed Ragab iD, Mohga Basseem iD, Dina S Aboul-Magd, Juraj Kronek, Zuzana Kroneková iD

Drug Development Research · 2026-11 · 87 (7)

DOI: 10.1002/ddr.70405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 09.11.2026. Verfasst von Ahmed Ragab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science (Boys), Al-Azhar University, Nasr City, Cairo, Egypt. Hauptthemen laut MEDLINE: Quinoxalines, Anti-Bacterial Agents, DNA Topoisomerase IV, Topoisomerase II Inhibitors. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Slovak Research and Development Agency, Slovak Grant Agency VEGA, Agentúra na Podporu Výskumu a Vývoja.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing new antibacterial agents is crucial for combating antibiotic resistance, which has predominantly emerged due to the overuse and misuse of antimicrobial agents. In this study, a new series of quinoxaline‐based compounds and imidazo[2,1‐ a ]isoindole derivatives were synthesized through the reaction of 1,2‐diaminobenzene with carbonyl‐rich compounds. The structures of these derivatives were confirmed through various spectroscopic analyses (IR, mass spectra, and 1 H/ 13 C NMR) and elemental analysis. Furthermore, their antibacterial activities were evaluated in vitro. Antibacterial efficacy was assessed against three gram‐positive ( Staphylococcus aureus , Staphylococcus pneumoniae , and Bacillus subtilis ) and three gram‐negative bacterial isolates ( Klebsiella pneumoniae , Escherichia coli , and Pseudomonas aeruginosa ); compounds 3 , 9 , and 14 demonstrated significant inhibitory activity against all tested isolates, with comparable MIC and MBC values. To further explore their antimicrobial potential, these three active synthesized compounds were assessed for their antibiofilm activity as anti‐infective agents against S. aureus (MDR224) and P. aeruginosa (MDR225). Notably, three compounds demonstrated superior bactericidal activity compared to ciprofloxacin (CIP), with undetectable resistance frequencies. Additionally, their potency for inhibiting DNA gyrase and DNA topoisomerase IV was found to be significantly promising, with low IC 50 values ranging from 6.75 ± 0.82 to 8.27 ± 1.2 µM and from 8.79 ± 0.24 to 10.33 ± 0.81 µM, respectively, in contrast to CIP, which exhibited IC 50 values of 47.68 ± 0.17 and 35.4 ± 0.55 µM. The in silico ADME, pharmacokinetic properties, docking simulations, and DFT calculations of the most promising candidates, 3 , 9 , and 14 , demonstrate significant antibacterial activity and considerable potential for future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinoxalinesAnti-Bacterial AgentsDNA Topoisomerase IVTopoisomerase II InhibitorsIsoindolesMicrobial Sensitivity TestsDNA GyraseGram-Positive BacteriaStructure-Activity RelationshipGram-Negative BacteriaMolecular Docking SimulationModels, Molecular

Stichwörter der Autor:innen

benzoimidazo[2,1‐a]isoindolemolecular modeling simulationsquinoxaline and Indeno[1,2‐b]quinoxalinetime‐kill and antibiofilm activity

Substanzen

QuinoxalinesAnti-Bacterial AgentsDNA Topoisomerase IVTopoisomerase II InhibitorsDNA GyraseIsoindoles

Autor:innen und Institutionen

  • Chemistry Department, Faculty of Science (Boys), Al-Azhar University, Nasr City, Cairo, Egypt.
  • Chemistry Department, Faculty of Science, Galala University, Galala City, Suez, Egypt.
  • Department for Biomaterials Research, Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovakia.
  • Chemistry Department, Faculty of Science, Al-Azhar University (Girls), Nasr City, Cairo, Egypt.
  • Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt.

ORCID-Profile: Ahmed Ragab, Mohga Basseem, Zuzana Kroneková

Förderung

  • Slovak Research and Development Agency
  • Slovak Grant Agency VEGA
  • Agentúra na Podporu Výskumu a Vývoja

Zitieren

APA

Ragab, A., Basseem, M., Aboul-Magd, D. S., Kronek, J., & Kroneková, Z. (2026). Discovery of New Quinoxaline, Tetracyclic‐Quinoxaline, and Imidazo[2,1‐ a ]isoindole Derivatives as Potent Antibacterial Candidates Targeting DNA Gyrase and Topoisomerase IV With Molecular Modeling Simulations. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70405

Vancouver

Ragab A, Basseem M, Aboul-Magd DS, Kronek J, Kroneková Z. Discovery of New Quinoxaline, Tetracyclic‐Quinoxaline, and Imidazo[2,1‐ a ]isoindole Derivatives as Potent Antibacterial Candidates Targeting DNA Gyrase and Topoisomerase IV With Molecular Modeling Simulations. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70405

BibTeX
@article{Ragab2026,
  author = {Ragab, Ahmed and Basseem, Mohga and Aboul-Magd, Dina S and Kronek, Juraj and Kroneková, Zuzana},
  title = {Discovery of New Quinoxaline, Tetracyclic‐Quinoxaline, and Imidazo[2,1‐ a ]isoindole Derivatives as Potent Antibacterial Candidates Targeting DNA Gyrase and Topoisomerase IV With Molecular Modeling Simulations},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {7},
  doi = {10.1002/ddr.70405}
}
Kostenlos starten →